| Catheter Precision, Inc. (NYSE American: VTAK) Reports First Purchase Order for LockeT in the Pacific Northwest Territory | 09/11 08:30 | accesswire.com |
| Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients | 09/05 09:00 | accesswire.com |
| Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory | 09/04 08:30 | accesswire.com |
| Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option | 09/03 16:15 | accesswire.com |
| Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering | 08/30 09:30 | accesswire.com |
| Catheter Precision, Inc. (NYSE American: VTAK) Reports Q2 2024 Highlights and Operational Performance Report | 08/14 08:45 | accesswire.com |
| Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology | 08/06 08:00 | accesswire.com |
| Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study | 07/25 08:00 | accesswire.com |
| Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO | 07/16 08:15 | accesswire.com |
| Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split | 07/15 08:00 | accesswire.com |